
University of Miami Sylvester Comprehensive Cancer Center
Playback speed
10 seconds
Magrolimab (Formerly 5F9) is a First-in-class Macrophage Immune Checkpoint Inhibitor Targeting CD47 in R/R AML
0 views
May 14, 2020
Comments 0
Login to view comments.
Click here to Login
MDS Biology and Treatment